Radiotherapy Reduces N-Oxides for Prodrug Activation in Tumors

Citations Over TimeTop 10% of 2022 papers

Abstract

Precisely activating chemotherapeutic prodrugs in a tumor-selective manner is an ideal way to cure cancers without causing systemic toxicities. Although many efforts have been made, developing spatiotemporally controllable activation methods is still an unmet challenge. Here, we report a novel prodrug activation strategy using radiotherapy (X-ray). Due to its precision and deep tissue penetration, X-ray matches the need for altering molecules in tumors through water radiolysis. We first demonstrated that N-oxides can be effectively reduced by hydrated electrons (e-_aq) generated from radiation both in tubes and living cells. A screening is performed to investigate the structure-reduction relationship and mechanism of the e-_aq-mediated reductions. We then apply the strategy to activate N-oxide prodrugs. The anticancer drug camptothecin (CPT)-based N-oxide prodrug shows a remarkable anticancer effect upon activation by radiotherapy. This radiation-induced in vivo chemistry may enable versatile designs of radiotherapy-activated prodrugs, which are of remarkable clinical relevance, as over 50% of cancer patients take radiotherapy.

Related Papers

• → Radiolysis of water at the surface of ZrO2 nanoparticles(2023)7 cited
• → Sites of Accumulation of the Antitumor Alkaloid Camptothecin inCamptotheca acuminata(1994)99 cited
• → Pulse radiolytic induced transient electrical conductance in liquid solutions. Part 1.—Technique and the radiolysis of water(1970)67 cited
• → Radiolysis of carboxylic compounds. Part 2.—Radiolysis of liquid acetic acid(1976)6 cited
• → Debromination of meso-substituted bromoanthracenes studied by pulse radiolysis and γ-radiolysis(1984)8 cited